2/13
06:29 am
rcus
Arcus Biosciences (NYSE:RCUS) was downgraded by analysts at Wells Fargo & Company from a "strong-buy" rating to a "hold" rating.
Medium
Report
Arcus Biosciences (NYSE:RCUS) was downgraded by analysts at Wells Fargo & Company from a "strong-buy" rating to a "hold" rating.
2/12
08:40 am
rcus
Rating for RCUS
Medium
Report
Rating for RCUS
2/12
08:40 am
rcus
Rating for RCUS
Medium
Report
Rating for RCUS
2/12
05:17 am
rcus
Arcus Biosciences downgraded to Equal Weight from Overweight at Wells Fargo
Medium
Report
Arcus Biosciences downgraded to Equal Weight from Overweight at Wells Fargo
2/12
05:17 am
rcus
Arcus Biosciences downgraded to Equal Weight from Overweight at Wells Fargo
Medium
Report
Arcus Biosciences downgraded to Equal Weight from Overweight at Wells Fargo
1/13
12:23 pm
rcus
Rating for RCUS
Low
Report
Rating for RCUS
1/13
12:23 pm
rcus
Rating for RCUS
Low
Report
Rating for RCUS
1/13
12:23 pm
rcus
Rating for RCUS
Low
Report
Rating for RCUS
1/12
04:30 pm
rcus
Arcus Biosciences upgraded to Buy from Neutral at Goldman Sachs
Medium
Report
Arcus Biosciences upgraded to Buy from Neutral at Goldman Sachs
1/12
04:30 pm
rcus
Arcus Biosciences upgraded to Buy from Neutral at Goldman Sachs
Medium
Report
Arcus Biosciences upgraded to Buy from Neutral at Goldman Sachs
1/12
04:30 pm
rcus
Arcus Biosciences upgraded to Buy from Neutral at Goldman Sachs
Medium
Report
Arcus Biosciences upgraded to Buy from Neutral at Goldman Sachs
1/8
07:10 am
rcus
Rating for RCUS
Medium
Report
Rating for RCUS
1/8
07:10 am
rcus
Rating for RCUS
Medium
Report
Rating for RCUS
1/8
05:03 am
rcus
Arcus Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
Medium
Report
Arcus Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
1/8
05:03 am
rcus
Arcus Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
Medium
Report
Arcus Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
12/15
08:44 am
rcus
Arcus Biosciences (NYSE:RCUS) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Arcus Biosciences (NYSE:RCUS) had its "buy" rating reaffirmed by analysts at UBS Group AG.
12/12
04:08 pm
rcus
Arcus Biosciences (NYSE:RCUS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Arcus Biosciences (NYSE:RCUS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..